Real-world data on the clinical use of secukinumab in pediatric generalized pustular psoriasis: A 48-week retrospective study

J Am Acad Dermatol. 2023 Jan;88(1):243-246. doi: 10.1016/j.jaad.2022.04.064. Epub 2022 May 16.
No abstract available

Keywords: generalized pustular psoriasis; pediatric patients; real-world study; secukinumab.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Child
  • Exanthema*
  • Humans
  • Psoriasis* / drug therapy
  • Retrospective Studies
  • Skin Diseases, Vesiculobullous*
  • Treatment Outcome

Substances

  • secukinumab
  • Antibodies, Monoclonal, Humanized